Pharming to attend Credit Suisse 31st Annual Healthcare Conference

LEIDEN, The Netherlands, Nov. 7, 2022 /PRNewswire/ -- Pharming Group N.V. ("Pharming") (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces that Pharming's Chief Executive Officer, Sijmen de Vries, and Chief Medical Officer, Anurag Relan, will attend the Credit Suisse 31^st Annual Healthcare Conference in Rancho Palos Verdes, California, November 7-10, 2022.

Pharming's CEO and CMO will be available for one-to-one investor and corporate meetings.

For more information about the conference, or to schedule a one-to-one with Pharming's management team, please contact your Credit Suisse representative, or send an email to Pharming's Investor Relations team to [email protected].

About Pharming Group N.V.

Pharming Group N.V. (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) is a global biopharmaceutical company dedicated to transforming the lives of patients with rare, debilitating, and life-threatening diseases. Pharming is commercializing and developing an innovative portfolio of protein replacement therapies and precision medicines, including small molecules, biologics, and gene therapies that are in early to late-stage development. Pharming is headquartered in Leiden, Netherlands, and has employees around the globe who serve patients in over 30 markets in North America, Europe, the Middle East, Africa, and Asia-Pacific. For more information, visit www.pharming.com or follow us on LinkedIn.

For further public information, contact:

Pharming Group, Leiden, The Netherlands
Heather Robertson, Investor Relations & Corporate Communications Manager
T: +31 71 5247 400
E: [email protected]

FTI Consulting, London, UK 
Victoria Foster Mitchell/Alex Shaw
T: +44 203 727 1000

FTI Consulting, USA 
Jim Polson
T: +1 (312) 553-6730

LifeSpring Life Sciences Communication, Amsterdam, The Netherlands
Leon Melens
T: +31 6 53 81 64 27
E: [email protected]

Logo - https://mma.prnewswire.com/media/1778344/Pharming_Group_NV_Logo.jpg